These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31260518)

  • 1. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
    Jagger BW; Dowd KA; Chen RE; Desai P; Foreman B; Burgomaster KE; Himansu S; Kong WP; Graham BS; Pierson TC; Diamond MS
    J Infect Dis; 2019 Oct; 220(10):1577-1588. PubMed ID: 31260518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine.
    LaTourette PC; Awasthi S; Desmond A; Pardi N; Cohen GH; Weissman D; Friedman HM
    Vaccine; 2020 Nov; 38(47):7409-7413. PubMed ID: 33041105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
    Nelson CS; Jenks JA; Pardi N; Goodwin M; Roark H; Edwards W; McLellan JS; Pollara J; Weissman D; Permar SR
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Thermostable mRNA Vaccine against COVID-19.
    Zhang NN; Li XF; Deng YQ; Zhao H; Huang YJ; Yang G; Huang WJ; Gao P; Zhou C; Zhang RR; Guo Y; Sun SH; Fan H; Zu SL; Chen Q; He Q; Cao TS; Huang XY; Qiu HY; Nie JH; Jiang Y; Yan HY; Ye Q; Zhong X; Xue XL; Zha ZY; Zhou D; Yang X; Wang YC; Ying B; Qin CF
    Cell; 2020 Sep; 182(5):1271-1283.e16. PubMed ID: 32795413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a potent Zika virus vaccine using self-amplifying messenger RNA.
    Luisi K; Morabito KM; Burgomaster KE; Sharma M; Kong WP; Foreman BM; Patel S; Fisher B; Aleshnick MA; Laliberte J; Wallace M; Ruckwardt TJ; Gordon DN; Linton C; Ruggiero N; Cohen JL; Johnson R; Aggarwal K; Ko SY; Yang ES; Pelc RS; Dowd KA; O'Hagan D; Ulmer J; Mossman S; Sambor A; Lepine E; Mascola JR; Pierson TC; Graham BS; Yu D
    Sci Adv; 2020 Aug; 6(32):eaba5068. PubMed ID: 32821824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation.
    Miao L; Li L; Huang Y; Delcassian D; Chahal J; Han J; Shi Y; Sadtler K; Gao W; Lin J; Doloff JC; Langer R; Anderson DG
    Nat Biotechnol; 2019 Oct; 37(10):1174-1185. PubMed ID: 31570898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status of Zika Virus Vaccines: Successes and Challenges.
    Pattnaik A; Sahoo BR; Pattnaik AK
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32486368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines to prevent genital herpes.
    Egan K; Hook LM; LaTourette P; Desmond A; Awasthi S; Friedman HM
    Transl Res; 2020 Jun; 220():138-152. PubMed ID: 32272093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
    Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
    Front Immunol; 2019; 10():1424. PubMed ID: 31293584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection.
    Egan KP; Hook LM; Naughton A; Pardi N; Awasthi S; Cohen GH; Weissman D; Friedman HM
    PLoS Pathog; 2020 Jul; 16(7):e1008795. PubMed ID: 32716975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.
    Grubor-Bauk B; Wijesundara DK; Masavuli M; Abbink P; Peterson RL; Prow NA; Larocca RA; Mekonnen ZA; Shrestha A; Eyre NS; Beard MR; Gummow J; Carr J; Robertson SA; Hayball JD; Barouch DH; Gowans EJ
    Sci Adv; 2019 Dec; 5(12):eaax2388. PubMed ID: 31844662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
    Corbett KS; Flynn B; Foulds KE; Francica JR; Boyoglu-Barnum S; Werner AP; Flach B; O'Connell S; Bock KW; Minai M; Nagata BM; Andersen H; Martinez DR; Noe AT; Douek N; Donaldson MM; Nji NN; Alvarado GS; Edwards DK; Flebbe DR; Lamb E; Doria-Rose NA; Lin BC; Louder MK; O'Dell S; Schmidt SD; Phung E; Chang LA; Yap C; Todd JM; Pessaint L; Van Ry A; Browne S; Greenhouse J; Putman-Taylor T; Strasbaugh A; Campbell TA; Cook A; Dodson A; Steingrebe K; Shi W; Zhang Y; Abiona OM; Wang L; Pegu A; Yang ES; Leung K; Zhou T; Teng IT; Widge A; Gordon I; Novik L; Gillespie RA; Loomis RJ; Moliva JI; Stewart-Jones G; Himansu S; Kong WP; Nason MC; Morabito KM; Ruckwardt TJ; Ledgerwood JE; Gaudinski MR; Kwong PD; Mascola JR; Carfi A; Lewis MG; Baric RS; McDermott A; Moore IN; Sullivan NJ; Roederer M; Seder RA; Graham BS
    N Engl J Med; 2020 Oct; 383(16):1544-1555. PubMed ID: 32722908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine.
    Zhong Z; Portela Catani JP; Mc Cafferty S; Couck L; Van Den Broeck W; Gorlé N; Vandenbroucke RE; Devriendt B; Ulbert S; Cnops L; Michels J; Ariën KK; Sanders NN
    Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31450775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mRNA chemistry and manufacturing process on innate immune activation.
    Nelson J; Sorensen EW; Mintri S; Rabideau AE; Zheng W; Besin G; Khatwani N; Su SV; Miracco EJ; Issa WJ; Hoge S; Stanton MG; Joyal JL
    Sci Adv; 2020 Jun; 6(26):eaaz6893. PubMed ID: 32637598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.
    Shajahan A; Supekar NT; Gleinich AS; Azadi P
    Glycobiology; 2020 Dec; 30(12):981-988. PubMed ID: 32363391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus Mucosal Infection Provides Protective Immunity.
    Martínez LE; Garcia G; Contreras D; Gong D; Sun R; Arumugaswami V
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.
    Halabi J; Jagger BW; Salazar V; Winkler ES; White JP; Humphrey PA; Hirsch AJ; Streblow DN; Diamond MS; Moley K
    J Infect Dis; 2020 Apr; 221(9):1506-1517. PubMed ID: 31616920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.
    Hassan AO; Dmitriev IP; Kashentseva EA; Zhao H; Brough DE; Fremont DH; Curiel DT; Diamond MS
    Cell Rep; 2019 Sep; 28(10):2634-2646.e4. PubMed ID: 31484074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
    Slon-Campos JL; Dejnirattisai W; Jagger BW; López-Camacho C; Wongwiwat W; Durnell LA; Winkler ES; Chen RE; Reyes-Sandoval A; Rey FA; Diamond MS; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2019 Oct; 20(10):1291-1298. PubMed ID: 31477918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy.
    Wessel AW; Kose N; Bombardi RG; Roy V; Chantima W; Mongkolsapaya J; Edeling MA; Nelson CA; Bosch I; Alter G; Screaton GR; Fremont DH; Crowe JE; Diamond MS
    Nat Commun; 2020 Oct; 11(1):5278. PubMed ID: 33077712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.